Pharma Focus Asia
KP - Choose our fully recyclable blister films

ACM Biolabs Announced Positive Phase I Trial Results for SARS-CoV-2 Booster Vaccine

Tuesday, September 05, 2023

ACM Biolabs has announced positive top-line findings from the Phase I trial of ACM-001, marking a significant milestone in their first clinical-stage development programme.

ACM-001 is a booster vaccine designed to enhance immunity against SARS-CoV-2, the causative agent of COVID-19. It consists of a spike-protein component sourced from the immune-evasive beta SARS-CoV-2 variant and an immunostimulant called CpG 7909, which is delivered using a polymer-based delivery technology.

This Phase I trial was conducted with the participation of thirty-six subjects at six different sites across Australia. The results demonstrate that ACM-001 was well-received and exhibited a high level of safety and tolerance when administered through both standard intramuscular injection and mucosal delivery routes.

The initial data related to immunogenicity is particularly promising. The intramuscular administration of the vaccine appears to have triggered a robust antibody response with broad reactivity. This immune response targets not only previous variants of the virus but also the presently circulating omicron strains, offering hope for effective protection against current and emerging forms of the virus.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoBora Pharmaceuticals - Free WhitepaperThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023
MasterControl - 6 Essential Features in an eQMS